glp-1 receptor agonist blood pressure reduction Ozempic, Wegovy & Mounjaro: emerging benefits and research Blood Pressure-Lowering Effects of SGLT2

doi: 10.1210/endo-128-6-3175

Falamarzi K, Malekpour M, Tafti MF, Azarpira N, Behboodi M, Zarei M

[DOI] [PMC free article] [PubMed] [Google Scholar] 893.Jacobsen L.V., Flint A., Olsen A.K., Ingwersen S.H

doi: 10.2337/diabetes.47.4.632

*Correspondence: Qiyuan Keith Liu, [email protected]

rxlist.com (Byetta ) rxlist.com (Byduron ) extended release formulation Keywords Liraglutide Trade Names: Victoza & generic Pharmacology: GLP-1 analog mechanism of action is the same as exenatide Indications: an adjunct to diet and exercise to improve glycemic control in type 2 diabetes mellitus to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke) in adults with type 2 diabetes mellitus and established cardiovascular disease Pharmacokinetics: once-daily injection Side Effects: Most common : nausea, diarrhea, vomiting (similar to exenatide) Black Box Warning: RISK OF THYROID C-CELL TUMORS References: Masharani U, Kroon L (2024): Pancreatic Hormones & Antidiabetic Drugs (Chapter 41)